James N Topper's Net Worth

-$11.5 Million

Who is James N Topper?

James N Topper does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include GLAUKOS Corp, Tarsus Pharmaceuticals, Inc., ALPINE IMMUNE SCIENCES, INC., COLLEGIUM PHARMACEUTICAL, INC, Phathom Pharmaceuticals, Inc., ANAPTYSBIO, INC, ProNAi Therapeutics Inc, Mirum Pharmaceuticals, Inc., AMICUS THERAPEUTICS INC, Frazier Lifesciences Acquisition Corp, Allena Pharmaceuticals, Inc., Entasis Therapeutics Holdings Inc., Passage BIO, Inc., Arcutis Biotherapeutics, Inc., LA JOLLA PHARMACEUTICAL CO, Aptinyx Inc., HilleVax, Inc., PORTOLA PHARMACEUTICALS INC, and NewAmsterdam Pharma Co N.V..

SEC CIK

James N Topper's CIK is 0001341382

Past Insider Trading and Trends

2020 was James N Topper's most active year for acquiring shares with 10 total transactions. James N Topper's most active month to acquire stocks was the month of April. 2024 was James N Topper's most active year for disposing of shares, totalling 8 transactions. James N Topper's most active month to dispose stocks was the month of April. 2020 saw James N Topper paying a total of $15,010,000.00 for 2,092,941 shares, this is the most they've acquired in one year. In 2023 James N Topper cashed out on 145,251 shares for a total of $0.00, their largest year based on trade value.